Nhale Inc. (NHLE) Garners Resources for Participation and Growth in $10B Legal Cannabis Market
Nhale understands legal marijuana is among the fastest-growing markets in the United States. The company is also well aware that this market is growing at a rate trending to outpace the expansion of the global smartphone market according a widely known American online news publication. It is within this prospective $10 billion market by 2018 that NHLE endeavors to build shareholder value through its acquiring of companies positioned to make a significant impact for medical and recreational purposes.
The marijuana industry’s growth goes hand in hand with a pervasive shift in the public’s attitude toward pot. Gallup polls conducted have found that for the first time in history, more than half of Americans think pot should be legal for both medical and recreational purposes. A CNN documentary explored marijuana’s benefits for a mainstream audience and found individuals are increasingly using the plant’s medicinal properties to treat symptoms even in children. And if that isn’t an exclamation point revealing a shift in public attitude, a coalition of conservative Mormon mothers in Utah lobbying for safe access to cannabis oil for their epileptic children should be.
Nhale is a company with a mission to be a leader in the cannabis industry through the acquisition of proven, early stage companies in the marijuana space. Nhale focuses its efforts at promoting industry awareness and develop economically sustainable partnerships while increasing shareholder value. The company’s strategically pursues accomplishing such goals as conducting product due diligence that will result in the commercialization of well-manufactured, forward-looking products, offering its products to consumers in a responsible manner and maintaining the highest ethical standards in all business endeavors.
In a move that defines the company’s commitment to execute on their corporate strategy, the company announced last month it has executed a term sheet for $10 million in debt financing with Four Twenty Investments, Inc., a Toronto-based private investment group. Four Twenty is focused on the financing and strategic investments of medical marijuana and similar companies involved in the cannabis industry. Nhale will utilize the proceeds of the financing to complete its intended acquisitions of revenue generating marijuana operations in states where recreational and/or medical marijuana has been legalized.
For more information on the company, visit www.nhaleinc.com/investors.html
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
Nhale understands legal marijuana is among the fastest-growing markets in the United States. The company is also well aware that this market is growing at a rate trending to outpace the expansion of the global smartphone market according a widely known American online news publication. It is within this prospective $10 billion market by 2018 that NHLE endeavors to build shareholder value through its acquiring of companies positioned to make a significant impact for medical and recreational purposes.
The marijuana industry’s growth goes hand in hand with a pervasive shift in the public’s attitude toward pot. Gallup polls conducted have found that for the first time in history, more than half of Americans think pot should be legal for both medical and recreational purposes. A CNN documentary explored marijuana’s benefits for a mainstream audience and found individuals are increasingly using the plant’s medicinal properties to treat symptoms even in children. And if that isn’t an exclamation point revealing a shift in public attitude, a coalition of conservative Mormon mothers in Utah lobbying for safe access to cannabis oil for their epileptic children should be.
Nhale is a company with a mission to be a leader in the cannabis industry through the acquisition of proven, early stage companies in the marijuana space. Nhale focuses its efforts at promoting industry awareness and develop economically sustainable partnerships while increasing shareholder value. The company’s strategically pursues accomplishing such goals as conducting product due diligence that will result in the commercialization of well-manufactured, forward-looking products, offering its products to consumers in a responsible manner and maintaining the highest ethical standards in all business endeavors.
In a move that defines the company’s commitment to execute on their corporate strategy, the company announced last month it has executed a term sheet for $10 million in debt financing with Four Twenty Investments, Inc., a Toronto-based private investment group. Four Twenty is focused on the financing and strategic investments of medical marijuana and similar companies involved in the cannabis industry. Nhale will utilize the proceeds of the financing to complete its intended acquisitions of revenue generating marijuana operations in states where recreational and/or medical marijuana has been legalized.
For more information on the company, visit www.nhaleinc.com/investors.html
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
